美国腹壁疝修补术式与结局趋势
该回顾性队列研究基于2007–2015年接受择期腹壁疝修补的Medicare受益人,描述微创、补片及肌筋膜松解的使用趋势及5年再手术率。结果显示微创从2.1%升至22.2%,补片从63.2%升至72.5%,肌筋膜松解从1.8%升至16.3%;5年复发再手术率为14.1%,且随时间略有改善。
要点
- 微创、补片及肌筋膜松解在腹壁疝修补中的使用显著增加。
- 5年复发再手术率为14.1%,2013–2015年无再手术生存率升至87.8%。
- 分析未证实因果关系,但再手术率改善与术式变化同步。
核心结论
- 腹壁疝修补术式向微创、补片和肌筋膜松解演变,同期复发再手术率略有改善,但未证实因果关系。
主要发现
- 2007–2018年微创从2.1%升至22.2%,补片从63.2%升至72.5%,肌筋膜松解从1.8%升至16.3%。
- 总体5年复发再手术率为14.1%(95%CI 14.0%–14.1%)。
- 2007–2009年无再手术生存率84.9%(95%CI 84.8%–84.9%),2010–2012年85.7%(95%CI 85.6%–85.7%),2013–2015年87.8%(95%CI 87.7%–87.9%)。
临床怎么用
- 了解腹壁疝修补术式演变趋势及复发再手术率的人群水平数据。
- 微创、补片和肌筋膜松解的使用增加与再手术率改善同步,但需个体化决策。
局限性
- 回顾性设计不能推断因果关系。
- 仅纳入Medicare受益人,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe national trends in surgical technique and rates of reoperation for recurrence for patients undergoing ventral hernia repair (VHR) in the United States. BACKGROUND: Surgical options for VHR, including minimally invasive approaches, mesh implantation, and myofascial release, have expanded considerably over the past 2 decades. Their dissemination and impact on population-level outcomes is not well characterized. METHODS: We conducted a retrospective cohort study of Medicare beneficiaries undergoing elective, inpatient umbilical, ventral, or incisional hernia repair between 2007 and 2015. Cox proportional hazards models were used to estimate the adjusted proportion of patients who remained free from reoperation for hernia recurrence up to 5 years after surgery. RESULTS: One hundred fort-one thousand two hundred sixty-one patients underwent VHR during the study period. Between 2007 and 2018, the use of minimally invasive surgery increased from 2.1% to 22.2%, mesh use increased from 63.2% to 72.5%, and myofascial release increased from 1.8% to 16.3%. Overall, the 5-year incidence of reoperation for recurrence was 14.1% [95% confidence interval (CI) 14.0%-14.1%]. Over time, patients were more likely to remain free from reoperation for hernia recurrence 5 years after surgery [2007-2009 reoperation-free survival: 84.9% (95% CI 84.8%-84.9%); 2010-2012 reoperation-free survival: 85.7% (95% CI 85.6%-85.7%); 2013-2015 reoperation-free survival: 87.8% (95% CI 87.7%-87.9%)]. CONCLUSIONS: The surgical treatment of ventral and incisional hernias has evolved in recent decades, with more patients undergoing minimally invasive repair, receiving mesh, and undergoing myofascial release. Although our analysis does not address causality, rates of reoperation for hernia recurrence improved slightly contemporaneous with changes in surgical technique.
引用
- Howard R, Thumma J, Ehlers A, et al. Trends in Surgical Technique and Outcomes of Ventral Hernia Repair in The United States. Ann Surg. 2022. PMID: 35920549. doi:10.1097/SLA.0000000000005654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。